Qube Research & Technologies (QRT)
ORTX

Qube Research & Technologies (QRT)’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-172,579
Closed -$2.84M – 5016
2023
Q4 		$2.84M Buy
172,579
+172,576
+5,752,533% +$2.72M 0.01% 1355
2023
Q3 		$23 Buy
+3
New +$16 ﹤0.01% 3874
2021
Q3 		– Sell
-9,449
Closed -$415K – 2923
2021
Q2 		$415K Buy
+9,449
New +$526K ﹤0.01% 1376

Qube Research & Technologies (QRT)'s ORTX Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 172,579 shares — an estimated $2.84M sold.

Qube Research & Technologies (QRT) first reported a position in ORTX in Q2 2021 and held it in 3 quarters. The position peaked at $2.84M in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 172,579 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $2.84M.
  • Qube Research & Technologies (QRT) first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2021 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Orchard Therapeutics plc American Depositary Shares position peaked at $2.84M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.